At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vitamin D and Prostate Cancer: A Randomized Clinical Study
In Brief
A Phase 2 clinical trial evaluating cholecalciferol and placebo for Prostate Cancer. Completed, enrolled 50 participants across 2 sites.
Detailed Summary
The study population will be 80 adult men who have been diagnosed with prostate cancer who are scheduled to have their prostate surgically removed at either the Medical University of South Carolina (MUSC) or the Ralph H. Johnson VAMC, both located in Charleston, SC. The men will be randomized into two groups: one group will take vitamin D3 supplementation and the other will take a placebo. Blood levels of vitamin D3 will be obtained at the beginning of the study and again after two months, just prior to the surgical procedure (prostatectomy). Prostate tissue will be obtained from the surgical procedure and studied for the effect of vitamin D on the prostate cancer cells.
Study Details
Timeline
Interventions
softgels 4000 IU daily for approximately two months prior to surgery (prostatectomy).
softgel containing no active ingredient daily for approximately two months prior to surgery (prostatectomy).